KCM
GILD icon

Karp Capital Management’s Gilead Sciences GILD Stock Holding History

Karp Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,172
Closed -$115K – 165
2015
Q3 		$115K Buy
1,172
+1,090
+1,329% +$121K 0.08% 121
2015
Q2 		$10K Buy
+82
New +$8.96K 0.01% 293

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Karp Capital Management's GILD Position: Q4 2015 in Review

Karp Capital Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 1,172 shares — an estimated $115K sold.

Karp Capital Management first reported a position in GILD in Q2 2015 and held it in 2 quarters. The position peaked at $115K in Q3 2015. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Karp Capital Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • Karp Capital Management sold 1,172 Gilead Sciences shares in Q4 2015, an estimated $115K.
  • Karp Capital Management first reported a position in Gilead Sciences in Q2 2015 and held it in 2 quarters.
  • Karp Capital Management's Gilead Sciences position peaked at $115K in Q3 2015.
  • 1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Karp Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.